| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 17 | 2025 | 276 | 5.410 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 9 | 2021 | 10 | 3.700 |
Why?
|
| Neoplasms | 14 | 2025 | 766 | 3.700 |
Why?
|
| Liposomes | 15 | 2018 | 142 | 3.080 |
Why?
|
| Colonic Neoplasms | 6 | 2021 | 116 | 2.890 |
Why?
|
| Drug Delivery Systems | 12 | 2023 | 216 | 2.820 |
Why?
|
| Doxorubicin | 10 | 2019 | 74 | 2.370 |
Why?
|
| Hyperthermia, Induced | 8 | 2020 | 30 | 2.280 |
Why?
|
| Melanoma | 4 | 2023 | 128 | 2.220 |
Why?
|
| Contrast Media | 5 | 2018 | 94 | 2.110 |
Why?
|
| Anti-Bacterial Agents | 9 | 2018 | 497 | 1.910 |
Why?
|
| Algorithms | 5 | 2022 | 422 | 1.880 |
Why?
|
| Antibiotics, Antineoplastic | 5 | 2019 | 31 | 1.740 |
Why?
|
| Immunotherapy | 6 | 2025 | 141 | 1.720 |
Why?
|
| Calreticulin | 2 | 2025 | 4 | 1.670 |
Why?
|
| CD40 Antigens | 3 | 2023 | 14 | 1.610 |
Why?
|
| Antineoplastic Agents | 8 | 2021 | 658 | 1.590 |
Why?
|
| Soybeans | 4 | 2019 | 35 | 1.470 |
Why?
|
| Temperature | 8 | 2018 | 207 | 1.400 |
Why?
|
| Melanoma, Experimental | 2 | 2021 | 29 | 1.400 |
Why?
|
| Ascomycota | 4 | 2019 | 21 | 1.370 |
Why?
|
| Animals | 32 | 2025 | 10078 | 1.360 |
Why?
|
| Salmonella | 3 | 2018 | 7 | 1.360 |
Why?
|
| Ciprofloxacin | 3 | 2018 | 19 | 1.270 |
Why?
|
| Staphylococcus aureus | 3 | 2018 | 115 | 1.160 |
Why?
|
| Tumor Microenvironment | 4 | 2025 | 156 | 1.150 |
Why?
|
| Plant Diseases | 4 | 2021 | 36 | 1.110 |
Why?
|
| Mice | 17 | 2023 | 4472 | 1.030 |
Why?
|
| Comovirus | 1 | 2025 | 1 | 0.990 |
Why?
|
| Dog Diseases | 1 | 2025 | 29 | 0.980 |
Why?
|
| Peptides | 2 | 2018 | 280 | 0.940 |
Why?
|
| Oryza | 4 | 2020 | 37 | 0.910 |
Why?
|
| Plant Proteins | 4 | 2020 | 64 | 0.900 |
Why?
|
| Proton Therapy | 2 | 2014 | 28 | 0.880 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 92 | 0.850 |
Why?
|
| Gene Expression Regulation, Plant | 4 | 2020 | 69 | 0.830 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.820 |
Why?
|
| Genetic Variation | 2 | 2021 | 229 | 0.820 |
Why?
|
| Disease Resistance | 3 | 2019 | 18 | 0.820 |
Why?
|
| Vaccination | 3 | 2020 | 175 | 0.800 |
Why?
|
| Drug Carriers | 8 | 2019 | 110 | 0.800 |
Why?
|
| Ultrasonography | 4 | 2019 | 229 | 0.760 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 122 | 0.760 |
Why?
|
| Dendritic Cells | 1 | 2023 | 142 | 0.750 |
Why?
|
| O Antigens | 1 | 2021 | 1 | 0.740 |
Why?
|
| Combined Modality Therapy | 6 | 2021 | 290 | 0.740 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 27 | 0.730 |
Why?
|
| Salmonella Infections | 2 | 2012 | 18 | 0.730 |
Why?
|
| Drug Liberation | 3 | 2016 | 24 | 0.730 |
Why?
|
| Multigene Family | 1 | 2021 | 50 | 0.720 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 35 | 0.720 |
Why?
|
| Proteins | 2 | 2022 | 245 | 0.720 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 45 | 0.700 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 1405 | 0.700 |
Why?
|
| Ultrasonic Therapy | 1 | 2020 | 4 | 0.690 |
Why?
|
| Humans | 28 | 2023 | 27116 | 0.680 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 55 | 0.680 |
Why?
|
| Heating | 1 | 2019 | 6 | 0.670 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 37 | 0.670 |
Why?
|
| Ultrasonics | 2 | 2021 | 7 | 0.670 |
Why?
|
| Tuberculosis, Miliary | 1 | 2019 | 1 | 0.670 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 45 | 0.670 |
Why?
|
| Immunophenotyping | 1 | 2019 | 59 | 0.660 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 81 | 0.660 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 63 | 0.660 |
Why?
|
| Polymers | 3 | 2017 | 114 | 0.660 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 8 | 0.660 |
Why?
|
| Sequence Analysis, Protein | 1 | 2019 | 15 | 0.650 |
Why?
|
| Models, Statistical | 1 | 2020 | 122 | 0.640 |
Why?
|
| Ergosterol | 1 | 2019 | 2 | 0.640 |
Why?
|
| Fluorocarbons | 2 | 2016 | 6 | 0.640 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 1268 | 0.640 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 367 | 0.630 |
Why?
|
| Elastin | 1 | 2018 | 20 | 0.600 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 64 | 0.590 |
Why?
|
| Abscess | 1 | 2018 | 24 | 0.590 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 6 | 0.570 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 270 | 0.560 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 69 | 0.560 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 39 | 0.550 |
Why?
|
| Thermometry | 1 | 2016 | 1 | 0.540 |
Why?
|
| Bacterial Proteins | 3 | 2015 | 474 | 0.530 |
Why?
|
| Taxoids | 1 | 2016 | 36 | 0.530 |
Why?
|
| Oxylipins | 2 | 2020 | 3 | 0.530 |
Why?
|
| Cyclopentanes | 2 | 2020 | 13 | 0.520 |
Why?
|
| Erythrocyte Membrane | 1 | 2016 | 22 | 0.520 |
Why?
|
| Bacteria | 1 | 2018 | 264 | 0.500 |
Why?
|
| Cytokines | 3 | 2025 | 440 | 0.480 |
Why?
|
| Nanomedicine | 2 | 2012 | 62 | 0.460 |
Why?
|
| Immunomodulation | 2 | 2025 | 20 | 0.460 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2016 | 811 | 0.440 |
Why?
|
| Drug Therapy | 1 | 2013 | 15 | 0.440 |
Why?
|
| Erythrocytes | 3 | 2020 | 83 | 0.440 |
Why?
|
| Male | 10 | 2025 | 13019 | 0.430 |
Why?
|
| Cattle | 4 | 2020 | 383 | 0.420 |
Why?
|
| Nanostructures | 2 | 2013 | 62 | 0.420 |
Why?
|
| Polylysine | 3 | 2017 | 14 | 0.400 |
Why?
|
| Serum Albumin, Bovine | 3 | 2017 | 22 | 0.400 |
Why?
|
| Dogs | 2 | 2025 | 505 | 0.400 |
Why?
|
| Polyethylene Glycols | 3 | 2017 | 93 | 0.380 |
Why?
|
| Mice, Nude | 3 | 2016 | 313 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 1496 | 0.370 |
Why?
|
| Plant Immunity | 2 | 2020 | 5 | 0.340 |
Why?
|
| Gentamicins | 1 | 2009 | 15 | 0.340 |
Why?
|
| Amino Acid Sequence | 2 | 2022 | 674 | 0.330 |
Why?
|
| Xanthomonas | 3 | 2020 | 6 | 0.330 |
Why?
|
| Hot Temperature | 3 | 2018 | 84 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 264 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 251 | 0.280 |
Why?
|
| Colon | 2 | 2019 | 119 | 0.280 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2022 | 172 | 0.280 |
Why?
|
| Butyrylcholinesterase | 2 | 2017 | 3 | 0.270 |
Why?
|
| Up-Regulation | 2 | 2019 | 241 | 0.260 |
Why?
|
| Biofilms | 3 | 2018 | 119 | 0.250 |
Why?
|
| Treatment Outcome | 3 | 2019 | 2283 | 0.230 |
Why?
|
| Tissue Distribution | 2 | 2016 | 132 | 0.220 |
Why?
|
| Cell Survival | 3 | 2014 | 395 | 0.220 |
Why?
|
| Nanotechnology | 2 | 2015 | 67 | 0.220 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2023 | 3 | 0.220 |
Why?
|
| Female | 7 | 2025 | 14633 | 0.220 |
Why?
|
| Immunity | 1 | 2023 | 26 | 0.220 |
Why?
|
| Pilot Projects | 1 | 2025 | 397 | 0.220 |
Why?
|
| Receptors, Adrenergic | 1 | 2023 | 10 | 0.210 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 29 | 0.210 |
Why?
|
| Plant Leaves | 3 | 2020 | 55 | 0.200 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2018 | 73 | 0.200 |
Why?
|
| Arabidopsis | 2 | 2020 | 65 | 0.200 |
Why?
|
| Immunity, Innate | 2 | 2014 | 212 | 0.200 |
Why?
|
| Drug Discovery | 1 | 2022 | 32 | 0.190 |
Why?
|
| Sequence Homology | 1 | 2021 | 9 | 0.190 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2021 | 9 | 0.180 |
Why?
|
| Spleen | 2 | 2020 | 109 | 0.180 |
Why?
|
| Open Reading Frames | 1 | 2021 | 37 | 0.180 |
Why?
|
| Cell Membrane | 2 | 2020 | 236 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 1 | 2021 | 54 | 0.180 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 64 | 0.180 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 68 | 0.180 |
Why?
|
| Y Chromosome | 1 | 2020 | 3 | 0.180 |
Why?
|
| Domestication | 1 | 2020 | 4 | 0.180 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 68 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2019 | 108 | 0.170 |
Why?
|
| CD47 Antigen | 1 | 2020 | 4 | 0.170 |
Why?
|
| Computational Biology | 2 | 2019 | 150 | 0.170 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 35 | 0.170 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2019 | 2 | 0.170 |
Why?
|
| Base Sequence | 1 | 2021 | 573 | 0.170 |
Why?
|
| Glucose Oxidase | 1 | 2019 | 7 | 0.170 |
Why?
|
| Aspergillus niger | 1 | 2019 | 10 | 0.170 |
Why?
|
| Antigens, Surface | 1 | 2019 | 39 | 0.160 |
Why?
|
| Antitubercular Agents | 1 | 2019 | 16 | 0.160 |
Why?
|
| Salicylic Acid | 2 | 2020 | 5 | 0.160 |
Why?
|
| Lipase | 2 | 2020 | 10 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2020 | 97 | 0.160 |
Why?
|
| Discriminant Analysis | 1 | 2019 | 16 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 70 | 0.160 |
Why?
|
| Cytotoxins | 1 | 2019 | 51 | 0.160 |
Why?
|
| Phenotype | 2 | 2018 | 667 | 0.160 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2019 | 23 | 0.160 |
Why?
|
| Fungal Proteins | 1 | 2019 | 72 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 280 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2020 | 147 | 0.160 |
Why?
|
| Glucocorticoids | 1 | 2019 | 114 | 0.160 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2016 | 26 | 0.160 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.150 |
Why?
|
| Phylogeny | 1 | 2021 | 462 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 123 | 0.150 |
Why?
|
| Protein Conformation | 1 | 2019 | 253 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 34 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 377 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 107 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 546 | 0.140 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 22 | 0.140 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2017 | 31 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 24 | 0.140 |
Why?
|
| Droughts | 1 | 2017 | 22 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 153 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 53 | 0.140 |
Why?
|
| Microbubbles | 1 | 2016 | 5 | 0.140 |
Why?
|
| Rabbits | 3 | 2012 | 275 | 0.140 |
Why?
|
| Quality of Life | 1 | 2021 | 465 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 466 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 445 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 288 | 0.130 |
Why?
|
| Theranostic Nanomedicine | 1 | 2016 | 22 | 0.130 |
Why?
|
| Erythrocyte Deformability | 1 | 2016 | 3 | 0.130 |
Why?
|
| Radiotherapy | 1 | 2016 | 39 | 0.130 |
Why?
|
| Random Allocation | 1 | 2016 | 148 | 0.130 |
Why?
|
| Aging | 1 | 2023 | 952 | 0.130 |
Why?
|
| Protein Transport | 1 | 2016 | 153 | 0.130 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 54 | 0.130 |
Why?
|
| Fungicides, Industrial | 1 | 2015 | 1 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2015 | 2 | 0.120 |
Why?
|
| Survival Rate | 1 | 2016 | 411 | 0.120 |
Why?
|
| Coumaric Acids | 1 | 2015 | 9 | 0.120 |
Why?
|
| Cellulase | 1 | 2014 | 1 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 13 | 0.120 |
Why?
|
| Endopeptidases | 1 | 2015 | 20 | 0.120 |
Why?
|
| Models, Biological | 2 | 2017 | 448 | 0.120 |
Why?
|
| Poaceae | 1 | 2015 | 21 | 0.120 |
Why?
|
| Skin | 1 | 2016 | 140 | 0.120 |
Why?
|
| Esterases | 1 | 2014 | 16 | 0.120 |
Why?
|
| Fermentation | 1 | 2015 | 47 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 626 | 0.120 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 23 | 0.120 |
Why?
|
| Particle Size | 2 | 2017 | 96 | 0.120 |
Why?
|
| Equipment Contamination | 1 | 2014 | 6 | 0.120 |
Why?
|
| Central Venous Catheters | 1 | 2014 | 6 | 0.120 |
Why?
|
| Sterilization | 1 | 2014 | 8 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2012 | 179 | 0.110 |
Why?
|
| Stilbenes | 1 | 2015 | 90 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 13 | 0.110 |
Why?
|
| Bacterial Secretion Systems | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cell Wall | 3 | 2019 | 64 | 0.110 |
Why?
|
| Electric Stimulation | 1 | 2014 | 253 | 0.110 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 106 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 164 | 0.110 |
Why?
|
| Transcriptome | 1 | 2014 | 205 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2017 | 635 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 589 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 115 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2012 | 12 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 26 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2011 | 12 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 44 | 0.100 |
Why?
|
| Teratoma | 1 | 2011 | 17 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 31 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 89 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 622 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2011 | 15 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 40 | 0.090 |
Why?
|
| Diffusion | 1 | 2009 | 37 | 0.080 |
Why?
|
| Crystallization | 1 | 2009 | 49 | 0.080 |
Why?
|
| Drug Compounding | 1 | 2009 | 29 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 24 | 0.080 |
Why?
|
| Surface Properties | 1 | 2009 | 132 | 0.080 |
Why?
|
| Materials Testing | 1 | 2009 | 86 | 0.080 |
Why?
|
| Brucella melitensis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Brucellosis | 1 | 2009 | 6 | 0.080 |
Why?
|
| Streptomycin | 1 | 2009 | 14 | 0.080 |
Why?
|
| Doxycycline | 1 | 2009 | 19 | 0.080 |
Why?
|
| Silicon Dioxide | 1 | 2009 | 42 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 516 | 0.080 |
Why?
|
| Salmonella typhimurium | 1 | 2009 | 68 | 0.080 |
Why?
|
| Microsatellite Repeats | 2 | 2020 | 55 | 0.080 |
Why?
|
| Adult | 1 | 2019 | 7490 | 0.070 |
Why?
|
| Paraoxon | 2 | 2017 | 2 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2017 | 9 | 0.070 |
Why?
|
| Cations | 2 | 2016 | 11 | 0.060 |
Why?
|
| Enzyme Stability | 2 | 2015 | 30 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 408 | 0.060 |
Why?
|
| Hydrolysis | 2 | 2015 | 58 | 0.060 |
Why?
|
| Equipment Design | 2 | 2015 | 211 | 0.060 |
Why?
|
| Kinetics | 2 | 2017 | 538 | 0.050 |
Why?
|
| Phantoms, Imaging | 2 | 2015 | 98 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2013 | 107 | 0.050 |
Why?
|
| Breeding | 1 | 2020 | 10 | 0.040 |
Why?
|
| Plants, Genetically Modified | 1 | 2020 | 23 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 198 | 0.040 |
Why?
|
| Haplotypes | 1 | 2020 | 279 | 0.040 |
Why?
|
| Alleles | 1 | 2020 | 345 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 750 | 0.040 |
Why?
|
| Secondary Metabolism | 1 | 2019 | 1 | 0.040 |
Why?
|
| Oxalic Acid | 1 | 2019 | 2 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 139 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2019 | 45 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 51 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 57 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 129 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 72 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 191 | 0.040 |
Why?
|
| Magnetic Fields | 1 | 2018 | 4 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2017 | 6 | 0.040 |
Why?
|
| Biological Variation, Population | 1 | 2017 | 3 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2017 | 22 | 0.040 |
Why?
|
| Genome, Plant | 1 | 2017 | 25 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 264 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 440 | 0.030 |
Why?
|
| Dynamic Light Scattering | 1 | 2016 | 1 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 226 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 443 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 94 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2016 | 118 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 55 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 239 | 0.030 |
Why?
|
| Echinocandins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Lipopeptides | 1 | 2015 | 4 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 165 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 34 | 0.030 |
Why?
|
| Lignin | 1 | 2015 | 15 | 0.030 |
Why?
|
| Cotton Fiber | 1 | 2015 | 2 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 129 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 512 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 100 | 0.030 |
Why?
|
| Solvents | 1 | 2015 | 38 | 0.030 |
Why?
|
| Detergents | 1 | 2015 | 24 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2015 | 40 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 537 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2015 | 61 | 0.030 |
Why?
|
| Nitrogen | 1 | 2015 | 68 | 0.030 |
Why?
|
| Software | 1 | 2015 | 121 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 68 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 262 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 36 | 0.030 |
Why?
|
| Genomics | 1 | 2015 | 116 | 0.030 |
Why?
|
| Glucans | 1 | 2013 | 6 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2013 | 45 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 143 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 66 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 205 | 0.030 |
Why?
|
| Virulence | 1 | 2013 | 144 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 325 | 0.030 |
Why?
|
| Inorganic Chemicals | 1 | 2012 | 1 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 365 | 0.020 |
Why?
|
| Electroporation | 1 | 2011 | 6 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 8 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 17 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 88 | 0.020 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2011 | 14 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 31 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 65 | 0.020 |
Why?
|
| Metals | 1 | 2012 | 39 | 0.020 |
Why?
|
| Karyotyping | 1 | 2011 | 24 | 0.020 |
Why?
|
| Lentivirus | 1 | 2011 | 16 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 29 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 100 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 168 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2011 | 1 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 6 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 313 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 1379 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 153 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 38 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 247 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 398 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 81 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 976 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 1554 | 0.020 |
Why?
|
| Liver | 1 | 2009 | 423 | 0.020 |
Why?
|